Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes.
暂无分享，去创建一个
H. Zar | G. Maartens | L. Wiesner | A. Van Rie | H. McIlleron | L. E. van der Laan | A. Hesseling | J. Winckler | A. Bekker | W. Smythe | H. Hundt | P. Smith